Arno Müller

3.4k citations

47 papers · 2.1k indexed · 1 hit paper · h-index 23

Impact in

Applied Microbiology and Biotechnology top 0.1%
- Antibiotic Use and Resistance
Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria

Papers in

Applied Microbiology and Biotechnology 26
- Antibiotic Use and Resistance 26
Molecular Medicine 7
- Antibiotic Resistance in Bacteria 7

Co-authors: Herman Goossens Vanessa Vankerckhoven Dominique L. Monnet Samuel Coenen Niels Adriaenssens Boudewijn Catry Peter Zarb Ann Versporten
Journals: Journal of Antimicrobial Chemotherapy (14 papers)British Journal of Clinical Pharmacology (3 papers)Drugs & Aging (2 papers)Clinical Infectious Diseases (1 paper)Pharmacoepidemiology and Drug Safety (1 paper)
Partner nations: Belgium France United Kingdom

In The Last Decade

Arno Müller

42 papers receiving 2.1k citations

Hit Papers

align trajectories log scale

The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use 2012 · 600 citations

Peers

Countries citing papers authored by Arno Müller

Since Specialization

Citations

This map shows the geographic impact of Arno Müller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arno Müller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arno Müller more than expected).

Fields of papers citing papers by Arno Müller

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arno Müller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arno Müller. The network helps show where Arno Müller may publish in the future.

Co-authors

The 25 scholars most cited alongside Arno Müller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Arno Müller Line = papers co-authored together Arno Müller links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Sammeln oder Simulieren? Eine vergleichende Evaluation zwischen Einsatzbegleitung und Einsatzsimulationen unter Teilnehmenden an NaSim25-Kursen Notfall + Rettungsmedizin ·Hanna Schröder, Syrina Beierle, Marc Felzen, Stefan Beckers, Arno Müller, Ulrich Walter, Andreas Follmann	2024	0
2	Ureteral access sheath-related injuries vs. post-operative infections. Is sheath insertion always needed? A prospective randomized study to understand the lights and shadows of this practice Actas Urológicas Españolas (English Edition) ·Giorgio Bozzini, D Jung, Umberto Besana, Ruqayyah Ismail, Antonio Luigi Pastore, Javier Otero, A. Macchi, Maria-Teresa-Botti-Rodrigues Santos, Alberto Breda, Ali Serdar Gözen, 鑓水一, Stefano Puliatti, Maria Chiara Sighinolfi, Bernardo Rocco, Inc. The Japan Internation Christian University Foundation, Arno Müller, Carlo Buizza	2021	7
3	Determinants of between-country differences in ambulatory antibiotic use and antibiotic resistance in Europe: a longitudinal observational study Journal of Antimicrobial Chemotherapy ·Aditya Candra, Christiaan Marais, Niel Hens, Samuel Coenen, Arno Müller, Herman Goossens, Philippe Beutels	2013	47
4	The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use Eurosurveillance ·Peter Zarb, B. Coignard, Krajewski Marcin, Arno Müller, Vanessa Vankerckhoven, K. Weist, Herman Goossens, (unknown), Susan Hopkins, Boudewijn Catry, Dominique L. Monnet, C. Suetens, 陈剑春 Hit paper breakdown →	2012	600
5	European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009) Journal of Antimicrobial Chemotherapy ·Haslam, Samuel Coenen, Niels Adriaenssens, Arno Müller, Girma Minalu, Christel Faes, Vanessa Vankerckhoven, Marc Aerts, Niel Hens, Geert Molenberghs, Herman Goossens, (unknown)	2011	44
6	Drug Utilization 75% (DU75%) in 17 European Hospitals (2000 - 2005): Results from the ESAC-2 Hospital Care Sub Project Current Clinical Pharmacology ·Peter Zarb, Faranak Ansari, Arno Müller, Vanessa Vankerckhoven, Peter Davey, Herman Goossens	2011	16
7	Parenteral versus Oral Administration of Systemic Antimicrobials in European Nursing Homes Drugs & Aging ·Agncia Nacional de guas, Boudewijn Catry, Katrien Latour, Karl Mertens, Vanessa Vankerckhoven, Arno Müller, Confucius (0551?-0479? av. J.-C.). Auteur du texte, Peter Zarb, Herman Goossens, Béatrice Jans	2011	6
8	European Surveillance of Antimicrobial Consumption (ESAC): quality appraisal of antibiotic use in Europe Journal of Antimicrobial Chemotherapy ·Niels Adriaenssens, Samuel Coenen, Ann Versporten, Arno Müller, Vanessa Vankerckhoven, Herman Goossens	2011	96
9	Antimicrobial Prescribing in Hospitalized Adults Stratified by Age Drugs & Aging ·Peter Zarb, Brice Amadéo, Arno Müller, Nico Drapier, Vanessa Vankerckhoven, Peter Davey, Herman Goossens	2011	6
10	A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use British Journal of Clinical Pharmacology ·Mamoon A. Aldeyab, Mary P. Kearney, James C. McElnay, Fidelma A. Magee, Geraldine Conlon, H. Heinrichs, Peter Davey, Arno Müller, Herman Goossens, Michael Scott	2010	43
11	Outpatient antibiotic use in the four administrations of the UK: cross-sectional and longitudinal analysis Journal of Antimicrobial Chemotherapy ·Peter Davey, Matus Ferech, Faranak Ansari, Arno Müller, Herman Goossens	2008	40
12	Exposure to antibacterial agents with QT liability in 14 European countries: trends over an 8‐year period British Journal of Clinical Pharmacology ·Emanuel Raschi, Elisabetta Poluzzi, Alejandro Elola, Arno Müller, Herman Goossens, Fabrizio De Ponti	2008	11
13	L'isolement septique des patients colonisés–infectés par Acinetobacter baumannii est-il totalement superflu, utile ou indispensable ? Médecine et Maladies Infectieuses ·Diego Setién Chamorro, Xavier Bertrand, Arno Müller, Michelle Thouverez, D. Talon	2006	1
14	Effect of individual- and group-level antibiotic exposure on MRSA isolation: a multilevel analysis Journal of Antimicrobial Chemotherapy ·Arno Müller	2006	56
15	Discrepancies between prescribed daily doses and WHO defined daily doses of antibacterials at a university hospital British Journal of Clinical Pharmacology ·Arno Müller, Dominique L. Monnet, D. Talon, Guarina Grullon, Xavier Bertrand	2006	77
16	Use of intranasal mupirocin to prevent methicillin-resistant Staphylococcus aureus infection in intensive care units Critical Care ·Arno Müller, D. Talon, Sirkku Aaltonen, Evelyne Belle, Mahnaz Esrafili, Xavier Bertrand	2005	30
17	Estimation of the Cumulative Incidence of Hospital-Acquired Bacteremia From Prevalence Data: A Formula Infection Control and Hospital Epidemiology ·Diego Setién Chamorro, Arno Müller, D. Talon, Xavier Bertrand	2005	7
18	Retour vers la sensibilité aux antibiotiques des souches de Staphylococcus aureus résistant à la méticilline (SARM) : relation entre génotype et antibiotype Pathologie Biologie ·Xavier Bertrand, Arno Müller, Michelle Thouverez, D. Talon	2004	3
19	Relationship between Spread of Methicillin‐ResistantStaphylococcus aureusand Antimicrobial Use in a French University Hospital Clinical Infectious Diseases ·Arno Müller, Frédéric Mauny, W. Smith, C. Cornette, José-Marı́a López-Lozano, Jean‐François Viel, D. Talon, Xavier Bertrand	2003	76
20	Modelling the usefulness of a dedicated cohort facility to prevent the dissemination of MRSA Journal of Hospital Infection ·D. Talon, J Shen, Arno Müller, M Sa Edilson, Ansgar Lyssy, Xavier Bertrand	2003	13

About Arno Müller

Arno Müller is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Clinical Biochemistry, Critical Care and Intensive Care Medicine and Epidemiology, having authored 47 papers that have together received 2.1k indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (26 papers), Pneumonia and Respiratory Infections (10 papers), Patient Satisfaction in Healthcare (10 papers), Antimicrobial Resistance in Staphylococcus (9 papers), Antibiotic Resistance in Bacteria (7 papers), Antibiotics Pharmacokinetics and Efficacy (7 papers), Bacterial Identification and Susceptibility Testing (6 papers) and Urinary Tract Infections Management (6 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (1.0k citations), Molecular Medicine (418 citations), Critical Care and Intensive Care Medicine (213 citations), Clinical Biochemistry (248 citations) and Infectious Diseases (490 citations). Arno Müller has collaborated with scholars based in Belgium, France and United Kingdom. Frequent co-authors include Herman Goossens, Vanessa Vankerckhoven, Dominique L. Monnet, Samuel Coenen, Niels Adriaenssens, Boudewijn Catry, Peter Zarb, Ann Versporten, C. Suetens and K. Weist. Their work appears in journals such as Journal of Antimicrobial Chemotherapy, British Journal of Clinical Pharmacology, Drugs & Aging, Clinical Infectious Diseases and Pharmacoepidemiology and Drug Safety.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact